The Board consists of seven members who are appointed by the Governor to three-year terms. There are two public members and five physician members. A member may serve only two consecutive terms. Members sometimes serve beyond the end of their terms before a replacement is appointed. Each member also serves on one or more of the Board's committees.
Candace Lapidus Sloane, M.D., Chair, Physician Member
Dr. Sloane was appointed to the Board in 2011. She earned BS (Magna Cum Laude) and MD degrees from Tufts University. She interned in Pediatrics at Children's Memorial Hospital in Chicago and served her Pediatric Residency at New York Hospital. She was a Pediatric Fellow and Instructor at Children's Hospital of Philadelphia. She later completed a Residency in Dermatology in the combined Boston University/Tufts University Medical School program, and was Chief Resident in Dermatology her third year. Dr. Sloane is board certified in Dermatology and Pediatric Dermatology. She served as an Instructor on the faculty of the University of Pennsylvania School of Medicine and Boston University School of Medicine, Director of the Pediatric and Adolescent Dermatology Service and Director of the Community Health Center Initiative in Dermatology at Boston Medical Center; an Assistant Professor of Dermatology and Pediatrics and Director, Fellowship in Primary Care Dermatology at the Boston University School of Medicine; and as an Assistant Professor of Dermatology and Pediatrics at the Alpert School of Medicine at Brown University. At Brown she was head of Pediatric Dermatology at Rhode Island Hospital, served as Dermatology Residency Director, and a Member of the Medical School Admissions Committee. Currently, she is a Clinical Assistant Professor of Pediatrics at Brown Medical School and a member of the Adjunct Medical Staff at Children’s Hospital Boston. She has lectured widely in the US and Europe, and authored or co-authored many publications in Pediatrics and Dermatology. Her special area of research interest is atopic dermatitis.
Kathleen Sullivan Meyer, Esq., Public Member, Vice Chair
Ms. Meyer was appointed to the Board in 2012, and is an Attorney at Law. She is a graduate of Newton College of the Sacred Heart, and received her Juris Doctor degree from Suffolk University in 1978. Ms. Meyer practiced at the Boston law firms of Snider, Crowe & Sbrogna and Lubin & Meyer, P.C. She is a member of the Massachusetts Bar Association and Boston Bar Association and is admitted to practice before the United States District Court, First Circuit Court of Appeals. Ms. Meyer has also served on the Board of Corporators of the Massachusetts Society for the Prevention of Cruelty to Children and as Chairman of the Strategic Planning Committee for the Fenn School Board of Trustees in Concord, Massachusetts. Ms. Meyer chairs the Licensing Committee.
R. Michael Scott, M.D., Physician Member
George Abraham, M.D., Physician Member
Paul R. DeRensis, Esq., Public Member
Attorney Paul R. DeRensis was appointed to the Board in 2013 as a Public Member. He is a graduate of Harvard College, Harvard Law School, and is a member of the bar of the State of New York and the Commonwealth of Massachusetts. He has been admitted to practice in numerous federal courts, including the Supreme Court of the United States, the United States Court of Appeals for the First Circuit, the United States Court of Appeals for the Second Circuit, and numerous United States District Courts. He is one of the founders of a Boston law firm. Mr. DeRensis’ law practice focuses on the representation of municipalities and public agencies. Mr. DeRensis also practices in the area of corporate governance and litigation, representing both non-profit and for profit corporations.
In addition to his legal perspective, he has practical hands-on familiarity with the problems faced by government agencies in that he has served local government as an appointed official, also as an elected member of a Town Planning Board and is a seven term elected member of a town Board of Selectmen. He has served a term as President of the Massachusetts Selectmen's Association and is a member of the Executive Committee of the Massachusetts Municipal Association and the Executive Committee of the Massachusetts Selectmen's Association. He is in his sixth term as a member of the Massachusetts Local Government Advisory Commission by appointment from the Governor.
Michael E. Henry, M.D., Physician Member
Dr. Michael Henry is a graduate of the University of Massachusetts Medical School in Worcester, Massachusetts. He completed his residency in adult psychiatry at the University of Massachusetts Medical Center. He then assumed the medical directorship of the university’s affiliated unit for mentally ill deaf people. After two years as director, he accepted and completed a fellowship in clinical pharmacology at the Intramural Program of the National Institutes of Mental Health in Bethesda, Maryland.
Dr. Henry subsequently joined Abbott Laboratories as the Associate Medical Director of the team developing Sertindole, a novel antipsychotic medication. Shortly after completion of the new drug application, he moved to McLean Hospital to become the Director of the Electroconvulsive Therapy Service. After 10 years as Director, he switched to a research affiliation at McLean Hospital and joined St. Elizabeth’s Medical Center in Brighton as the Chairman of Psychiatry. Subsequently, he was appointed Vice President of Mental Health for Steward Health.
During his tenure at Steward Health, Dr. Henry received recognition for his outstanding teaching from the Tuft’s University Medical Students and received the annual teaching award from the psychiatry residents in 2010. He also held the position of Director of Residency Training and was the Chairman of the Committee on Graduate Medical Education. He is currently the Director of Somatic Therapy and Medical Director of the Bipolar Clinic and Research Program at the Massachusetts General Hospital.
Dr. Henry’s research interests have been focused on the use of brain imaging techniques to study mood disorders and facilitate drug discovery. He has published over 25 journal articles and book chapters. He has presented this work both nationally and internationally.
Joseph P. Carrozza, Jr., M.D., Physician Member
Dr. Carrozza received his undergraduate degree from Georgetown University, College of Arts and Sciences, and his medical degree from the New York University School of Medicine. He completed internship, residency, and fellowship programs in Cardiovascular Medicine, and a fellowship in Interventional Cardiology at Beth Israel Hospital, Boston, MA. He was appointed to the medical staff of Beth Israel Hospital and to the faculty of Harvard Medical School in 1992.
In 2009, Dr. Carrozza was appointed Chief of Cardiovascular Medicine at Caritas (now Steward) St. Elizabeth’s Medical Center, Boston, and Vice President of the Caritas (now Steward) Cardiovascular Network, where he is responsible for the cardiovascular service line at eleven Steward hospitals. In 2010, he was appointed Professor of Medicine at the Tufts University School of Medicine.
Dr. Carrozza has spent the past twenty-two years as a practicing Interventional Cardiologist. He is the only remaining active interventional cardiologist in New England to have been part of the team that placed the first coronary stent in New England. He was the first interventional cardiologist in the world to perform rheolytic thrombectomy with the Angioject in a coronary artery, and he has proctored over 50 interventional cardiologists in the technique of coronary stenting and rotational atherectomy.
Dr. Carrozza has participated in over 75 clinical trials and has published over 100 articles in academic medical journals. He has served as the National Principal Investigator for four multicenter clinical trials.
Dr. Carrozza has been selected by Consumers Checkbook to “Best Cardiovascular Specialists Group” and “Top Doctors in Boston.”
This information is provided by the Board of Registration in Medicine.